Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.

García-Pedraza JÁ, García M, Martín ML, Gómez-Escudero J, Rodríguez-Barbero A, Román LS, Morán A.

Eur J Pharmacol. 2013 Aug 15;714(1-3):65-73. doi: 10.1016/j.ejphar.2013.05.045.

PMID:
23769743
2.

The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.

García-Pedraza JÁ, García M, Martín ML, San Román L, Morán A.

Eur J Pharmacol. 2014 May 15;731:80-7. doi: 10.1016/j.ejphar.2014.02.043.

PMID:
24675150
3.
4.
5.

Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats.

Morán A, Restrepo B, de Urbina AV, García M, Martín ML, Román LS.

Eur J Pharmacol. 2010 Sep 15;643(1):70-7. doi: 10.1016/j.ejphar.2010.06.013.

PMID:
20547148
6.

5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.

García-Pedraza JÁ, García M, Martín ML, Morán A.

Vascul Pharmacol. 2015 Sep;72:172-80. doi: 10.1016/j.vph.2015.05.003.

PMID:
26003124
7.
8.

Peripheral 5-HT1A and 5-HT7 serotonergic receptors modulate parasympathetic neurotransmission in long-term diabetic rats.

Restrepo B, Martín ML, San Román L, Morán A.

Exp Diabetes Res. 2010;2010:686734. doi: 10.1155/2010/686734.

9.

The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.

Villalón CM, Centurión D, Rabelo G, de Vries P, Saxena PR, Sánchez-López A.

Br J Pharmacol. 1998 Jul;124(5):1001-11.

10.

Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat.

Villalón CM, Contreras J, Ramírez-San Juan E, Castillo C, Perusquía M, Terrón JA.

Br J Pharmacol. 1995 Dec;116(8):3330-6.

11.

Characterization of mechanisms involved in presynaptic inhibition of sympathetic pressor effects induced by some 5-HT1 receptor antagonists.

Fernández MM, Calama E, Morán A, Martín ML, San Román L.

J Auton Pharmacol. 2000 Oct-Dec;20(5-6):313-23.

PMID:
11350497
12.

The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats.

García M, Morán A, Luisa Martín M, Barthelmebs M, San Román L.

Eur J Pharmacol. 2006 May 10;537(1-3):126-34.

PMID:
16630608
14.

5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.

Cohen ML, Schenck KW, Hemrick-Luecke SH.

J Pharmacol Exp Ther. 1999 Sep;290(3):1195-201.

15.

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.

Millan MJ, Gobert A, Rivet JM, Adhumeau-Auclair A, Cussac D, Newman-Tancredi A, Dekeyne A, Nicolas JP, Lejeune F.

Eur J Neurosci. 2000 Mar;12(3):1079-95.

PMID:
10762339
16.

Chronic sarpogrelate treatment reveals 5-HT7 receptor in the serotonergic inhibition of the rat vagal bradycardia.

García-Pedraza JÁ, García M, Martín ML, Eleno N, Morán A.

J Cardiovasc Pharmacol. 2016 Sep 20. [Epub ahead of print]

PMID:
27676327
17.

The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.

González-Hernández A, Manrique-Maldonado G, Lozano-Cuenca J, Muñoz-Islas E, Centurión D, Maassen VanDenBrink A, Villalón CM.

Eur J Pharmacol. 2011 Jun 1;659(2-3):233-43. doi: 10.1016/j.ejphar.2011.03.035.

PMID:
21473863
18.

Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats.

García-Pedraza JÁ, García M, Martín ML, Morán A.

Clin Exp Pharmacol Physiol. 2015 Jun;42(6):640-7. doi: 10.1111/1440-1681.12397.

PMID:
25854421
19.

Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.

Lozano-Cuenca J, Muñoz-Islas E, González-Hernández A, Centurión D, Cobos-Puc LE, Sánchez-López A, Pertz HH, Villalón CM.

Eur J Pharmacol. 2009 Jun 10;612(1-3):80-6. doi: 10.1016/j.ejphar.2009.03.072.

PMID:
19356724
20.

Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.

Sánchez-Lopez A, Centurión D, Vázquez E, Arulmani U, Saxena PR, Villalón CM.

Br J Pharmacol. 2003 Oct;140(4):725-35.

Items per page

Supplemental Content

Support Center